1. Home
  2. GSIW vs EVOK Comparison

GSIW vs EVOK Comparison

Compare GSIW & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • EVOK
  • Stock Information
  • Founded
  • GSIW 2016
  • EVOK 2007
  • Country
  • GSIW Hong Kong
  • EVOK United States
  • Employees
  • GSIW N/A
  • EVOK N/A
  • Industry
  • GSIW
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIW
  • EVOK Health Care
  • Exchange
  • GSIW Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • GSIW 12.3M
  • EVOK 7.1M
  • IPO Year
  • GSIW 2023
  • EVOK 2013
  • Fundamental
  • Price
  • GSIW $0.51
  • EVOK $4.99
  • Analyst Decision
  • GSIW
  • EVOK
  • Analyst Count
  • GSIW 0
  • EVOK 0
  • Target Price
  • GSIW N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • GSIW 11.7M
  • EVOK 9.5K
  • Earning Date
  • GSIW 12-31-2024
  • EVOK 03-13-2025
  • Dividend Yield
  • GSIW N/A
  • EVOK N/A
  • EPS Growth
  • GSIW N/A
  • EVOK N/A
  • EPS
  • GSIW N/A
  • EVOK N/A
  • Revenue
  • GSIW $1,313,795.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • GSIW N/A
  • EVOK $97.35
  • Revenue Next Year
  • GSIW N/A
  • EVOK $99.52
  • P/E Ratio
  • GSIW N/A
  • EVOK N/A
  • Revenue Growth
  • GSIW N/A
  • EVOK 100.35
  • 52 Week Low
  • GSIW $0.43
  • EVOK $3.54
  • 52 Week High
  • GSIW $15.00
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 46.14
  • EVOK 58.60
  • Support Level
  • GSIW $0.46
  • EVOK $4.68
  • Resistance Level
  • GSIW $1.25
  • EVOK $5.19
  • Average True Range (ATR)
  • GSIW 0.12
  • EVOK 0.31
  • MACD
  • GSIW 0.00
  • EVOK 0.03
  • Stochastic Oscillator
  • GSIW 9.31
  • EVOK 72.64

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: